je.st
news
Allergan generic drug firm bought for $40.5B
2015-07-28 00:44:29| Biotech - Topix.net
Israel's Teva Pharmaceutical Industries Ltd. said Monday it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company. Statements from both companies say the deal will see Allergan receive $33.75 billion in cash and shares of Teva valued Monday at $6.75 billion.
Tags: firm
drug
bought
generic
Category:Biotechnology and Pharmaceuticals